GLUCOCORTICOID-INDUCED OSTEOPOROSIS

Clinical trials for GLUCOCORTICOID-INDUCED OSTEOPOROSIS explained in plain language.

Never miss a new study

Get alerted when new GLUCOCORTICOID-INDUCED OSTEOPOROSIS trials appear

Sign up with your email to follow new studies for GLUCOCORTICOID-INDUCED OSTEOPOROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Can a bone drug reverse damage from common meds?

Disease control Recruiting now

This study is testing how well the approved drug Prolia works to improve bone density in people whose bones have weakened from taking steroid medications like prednisone. It will enroll 100 adults in China who are currently on steroid treatment and have low bone mass. Researchers…

Matched conditions: GLUCOCORTICOID-INDUCED OSTEOPOROSIS

Phase: PHASE4 • Sponsor: Amgen • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

GLUCOCORTICOID-INDUCED OSTEOPOROSIS

Get alerted when new GLUCOCORTICOID-INDUCED OSTEOPOROSIS trials appear

Can a bone drug reverse damage from common meds?